Table 4 Subgroup analysis of serum chloride and 90-day and 365-day mortality in COPD critically ill patients.
90-day mortality | 365-day mortality | |||||
|---|---|---|---|---|---|---|
95% CI | P | P for interaction | 95% CI | P | P for interaction | |
Age, years | 0.675 | 0.575 | ||||
≥ 72 | 0.95 (0.93, 0.97) | < 0.001 | 0.95 (0.93, 0.97) | < 0.001 | ||
< 72 | 0.98 (0.95, 1.01) | 0.137 | 0.97 (0.94, 0.99) | 0.008 | ||
Gender | 0.731 | 0.611 | ||||
Male | 0.95(0.93, 0.98) | < 0.001 | 0.95 (0.93, 0.97) | < 0.001 | ||
Female | 0.96 (0.94, 0.99) | 0.003 | 0.97 (0.95, 0.99) | 0.002 | ||
Weight, kg | 0.889 | 0.901 | ||||
< 78.38 | 0.95 (0.93, 0.97) | < 0.001 | 0.95 (0.93, 0.97) | < 0.001 | ||
≥ 78.38 | 0.98 (0.95, 1.00) | 0.100 | 0.97 (0.95, 0.99) | 0.006 | ||
Hypertension | 0.431 | 0.977 | ||||
No | 0.96 (0.94, 0.98) | < 0.001 | 0.96 (0.95, 0.98) | < 0.001 | ||
Yes | 0.98 (0.95, 1.02) | 0.272 | 0.96 (0.93, 0.98) | 0.002 | ||
Diabetes | 0.931 | 0.877 | ||||
No | 0.95 (0.93, 0.97) | < 0.001 | 0.95 (0.93, 0.96) | < 0.001 | ||
Yes | 1.00 (0.97, 1.04) | 0.828 | 0.99 (0.97, 1.02) | 0.688 | ||
Heart failure | 0.499 | 0.202 | ||||
No | 0.96 (0.93, 0.99) | 0.003 | 0.95 (0.93, 0.97) | < 0.001 | ||
Yes | 0.96 (0.94, 0.98) | 0.002 | 0.96 (0.94, 0.98) | < 0.001 | ||
Myocardial infarction | 0.220 | 0.098 | ||||
No | 0.96 (0.94, 0.98) | < 0.001 | 0.96 (0.94, 0.97) | < 0.001 | ||
Yes | 0.94 (0.89, 1.00) | 0.040 | 0.96 (0.91, 1.00) | 0.062 | ||
CKD | 0.424 | 0.209 | ||||
No | 0.96 (0.94, 0.98) | < 0.001 | 0.95 (0.93, 0.97) | < 0.001 | ||
Yes | 0.97 (0.94, 1.01) | 0.123 | 0.98 (0.96, 1.01) | 0.224 | ||
Stroke | 0.200 | 0.200 | ||||
No | 0.96 (0.95, 0.98) | < 0.001 | 0.96 (0.94, 0.98) | < 0.001 | ||
Yes | 0.93 (0.85, 1.01) | 0.087 | 0.95 (0.89, 1.01) | 0.123 | ||
